Pfizer has a made a $48 per share play for Array Biopharma, which values the cancer specialist at $11.4 billion. The offer – which is a 62% premium over Array’s closing share price on Friday – would ...
You’ve seen the headlines. Now let’s break them open. Sasha-Ann Simons connects you with the people behind the stories: experts, neighbors and newsmakers who shape the city we share. It’s news, ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results